TGFB1 and Dravet syndrome: To investigate whether the decline in TGF-β1 plasma concentrations can predict cognitive decline progression in DS individuals, we examined the association between plasma concentrations of TGF-β1 at baseline (T0) and the following rate of cognitive decline calculated for each individual as dTSI (DS subjects n = 36).